Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Acta Cir Bras ; 20 Suppl 1: 114-20, 2005.
Artículo en Portugués | MEDLINE | ID: mdl-16186978

RESUMEN

OBJECTIVE: To evaluate the effect of tamoxifen in the lipidic and renal profile in diabetic and control rats. METHODS: 40 female Wistar rats had been used (180-220g corporal weight), divided randomly in 4 groups: C (n = 10, received vehicle), T (n = 10, treated with tamoxifen, 0.3mg/kg/day), D (n = 10, diabetic induced by streptozotocin, 45mg/Kg) and DT (n = 10, diabetic treated with tamoxifen). Glucose, total cholesterol, triglyceride, total proteins, albumin, urea and creatinin were analyzed using Labtest Kits through the Cobas Mira analyzer (Germany, 1996). RESULTS: Group T presented a reduction of total cholesterol and triglyceride in relation to C, and group D an increase in relation to the other ones. About the total proteins it was observed an increasing in Group T in relation to C. The albumin diminished in groups D and DT in relation to C and T. The urea levels increased in groups D and DT in relation to C and T. CONCLUSION: In relation to the lipidic profile it was evidenced that during the period of 60 days the treatment with tamoxifen promoted a reduction in cholesterol and triglyceride levels in the serum, even associated to the condition of Diabetes mellitus.


Asunto(s)
Colesterol/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Antagonistas de Estrógenos/uso terapéutico , Metabolismo de los Lípidos/efectos de los fármacos , Tamoxifeno/uso terapéutico , Triglicéridos/sangre , Albúminas/análisis , Animales , Creatinina/sangre , Diabetes Mellitus Experimental/sangre , Femenino , Proteínas/análisis , Ratas , Ratas Wistar , Estreptozocina , Urea/sangre
2.
Acta Cir Bras ; 20 Suppl 1: 131-8, 2005.
Artículo en Portugués | MEDLINE | ID: mdl-16186981

RESUMEN

PURPOSE: Considering that important scientific advances have been obtained through studies based on experimental Diabetes mellitus, and that tamoxifen action in humans remains unknown, the aim of the present work is to follow the modifications promoted by diabetes and tamoxifen in the electrophoretic profile of plasmatic proteins. METHODS: It was used 27 Wistar female rats (180-250 body weight), randomicaly divided into five groups: C1 (n = 3, received vehicle), C2 (n = 3, no treatment), T (n =5, treated with tamoxifen, 0.3mg/Kg/day), D (n = 8, experimental diabetes by estreptozotocin, 45mg/Kg and DT (n = 8, diabetic treated with tamoxifen). The electrophoresis was accomplished in cellulose acetate. pH 8.6-8.8, TECNOW chamber, and the strains were stained by Ponceau S. The total proteins were determined by the Biuret method (Labtest). Proteinograms were obtained in densitometer BioSystems BTS-235. RESULTS: Albumin decreased progressively in the groups T, D and DT; a1 fraction increased in groups T and DT; a2 fraction increased in groups T and D, including a synergic effect in group DT; a fraction increased in groups T and D; a fraction increased in groups T, D and DT. CONCLUSIONS: The results indicate an acute phase resposta, with synergic effect of tamoxifen and diabetes, suggesting a probable hepatic lesion.


Asunto(s)
Proteínas Sanguíneas/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Tipo 1/sangre , Antagonistas de Estrógenos/farmacología , Tamoxifeno/farmacología , Análisis de Varianza , Animales , Glucemia/efectos de los fármacos , Electroforesis de las Proteínas Sanguíneas , Peso Corporal/efectos de los fármacos , Ciclo Estral/efectos de los fármacos , Femenino , Ratas , Ratas Wistar
3.
Acta cir. bras ; 20(supl.1): 114-120, 2005.
Artículo en Portugués | LILACS | ID: lil-414643

RESUMEN

OBJETIVO: avaliar o efeito do tamoxifeno no perfil lipídico e renal de ratos controles e diabéticos. MÉTODOS: Foram utilizados 40 ratos fêmeas Wistar (180-220g peso corporal), divididos randomicamente em 4 grupos: C (n=10, receberam veículo), T (n=10, tratados com tamoxifeno, 0,3mg/kg/dia), D (n=10, diabéticos induzidos por estreptozotocina, 45mg/Kg) e DT (n=10, diabéticos tratados com tamoxifeno). Foram dosados os analitos, glicose, colesterol total, triglicérides, proteínas totais, albumina, uréia e creatinina utilizando Kits Labtest através do analisador Cobas Mira (Alemanha,1996). RESULTADOS: o grupo T apresentou diminuição do colesterol total e triglicérides em relação ao C, e o grupo D um aumento em relação aos demais. Para as proteínas totais foi observado um aumento no Grupo T em relação ao C. A albumina diminuiu nos grupos D e DT em relação aos grupos C e T. Nos níveis de uréia houve um aumento no grupo D e DT em relação aos grupos C e T. CONCLUSÃO: Em relação ao perfil lipídico foi constatado que durante o período de 60 dias o tratamento com tamoxifeno promoveu uma diminuição dos níveis séricos de colesterol e triglicérides, mesmo associado a condição de Diabetes mellitus.


Asunto(s)
Animales , Femenino , Ratas , Colesterol/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Antagonistas de Estrógenos/uso terapéutico , Metabolismo de los Lípidos/efectos de los fármacos , Tamoxifeno/uso terapéutico , Triglicéridos/sangre , Albúminas/análisis , Creatinina/sangre , Diabetes Mellitus Experimental/sangre , Proteínas/análisis , Ratas Wistar , Estreptozocina , Urea/sangre
4.
An. bras. dermatol ; 61(5): 259-61, set.-out. 1986. ilus
Artículo en Portugués | LILACS | ID: lil-37226

RESUMEN

Com relato de dois casos de siringoma condróide, discutem-se a extensa sinonímia, as dificuldades clínico-diagnósticas e as características histopatológicas e evolutivas desta rara neoplasia anexial cutânea. Recomenda-se a busca ativa de mais casos para a melhor investigaçäo acerca da verdadeira natureza deste tumor


Asunto(s)
Persona de Mediana Edad , Humanos , Masculino , Adenoma de las Glándulas Sudoríparas/patología , Cara , Neoplasias Cutáneas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA